We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare

Launched by STATE UNIVERSITY OF NEW YORK - DOWNSTATE MEDICAL CENTER · Jun 14, 2023

Keywords

ClinConnect Summary

The We Care About Brooklyn trial is studying a special program called WeCAB, designed to help pregnant Black women in Central Brooklyn get better care after giving birth. The main goal of this study is to see if women who receive support from a WeCAB community health worker are more likely to attend their postpartum check-ups compared to those who receive standard care. This program focuses on providing guidance and support through digital tools to help mothers navigate their healthcare needs.

To participate in this study, women must be between 18 and 49 years old, live in Central Brooklyn, identify as Black, and speak either English or Haitian Creole. They should also plan to deliver at University Hospital at Downstate. Participants will be followed from 13 weeks into their pregnancy until three months after giving birth, allowing researchers to see how well the WeCAB program works in improving follow-up care. This trial is currently looking for volunteers, and it aims to make a positive difference in maternal health in the community.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Eligible participants for the pilot RCT will be patients
• • aged 18-49 years (childbearing age)
• • residing in a Central Brooklyn zip code
• • self-reporting as Black,
• • who speak English or Haitian Creole, and
• • plan to deliver or present for delivery at University Hospital at Downstate (UHD).
• • In NYC, SMM increases incrementally with later entry into prenatal care (1st trimester: 208/10,000 deliveries; 2nd trimester: 252/10,000; 3rd trimester: 297/10,000; None: 575/10,000). 3 Accordingly, in order to capture the full range of SMM risk profiles for our pilot study, any pregnant patient/client visiting our clinics will be eligible for enrollment from 13 weeks gestation through delivery, thus allowing follow-up to 3 months post-partum within the 2-year study timeline.
• Exclusion Criteria:
• • Patients planning to move outside of New York City in the ensuing 3 months post-partum
• • Patients demonstrating an impairment that limits their ability to provide informed consent.